Decker Retirement Planning
INO icon

Decker Retirement Planning’s Inovio Pharmaceuticals INO Stock Holding History

Decker Retirement Planning’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$205 Hold
168
– – ﹤0.01% 339
2026
Q2 		$185 Buy
+168
New +$199 ﹤0.01% 429

Other funds holding INO

Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
LexAurum Advisors
LexAurum Advisors Overland Park, Kansas $893M AUM
Prime Capital Investment Advisors
Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return
Mount Yale Investment Advisors
Mount Yale Investment Advisors Denver, Colorado $5.96B AUM 22.06% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Signature Estate & Investment Advisors
Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return
Covestor
Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Decker Retirement Planning's INO Position: Q3 2026 in Review

Decker Retirement Planning held its Inovio Pharmaceuticals (INO) position steady in Q3 2026 at 168 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Decker Retirement Planning first reported a position in INO in Q2 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Decker Retirement Planning held 168 shares of Inovio Pharmaceuticals worth $205 as of Q3 2026.
  • Decker Retirement Planning left its Inovio Pharmaceuticals share count unchanged in Q3 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Decker Retirement Planning's portfolio in Q3 2026, its #339 holding.
  • Decker Retirement Planning first reported a position in Inovio Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Decker Retirement Planning's 13F filing for Q3 2026, filed 19 Oct 2026.